Fox Run Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Fox Run Management’s Portfolio AMLX Stock Details AMLX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$428K	Buy
2025 Q1	–	Sell
2024 Q4	$44.6K	Buy
2024 Q1	–	Sell
2023 Q4	$324K	Buy
2023 Q3	$311K	Sell
2023 Q2	$388K	Buy
2023 Q1	$367K	Buy